FDA grants ocrelizumab 'breakthrough therapy designation...

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

FDA grants ocrelizumab 'breakthrough therapy designation...

Postby MSUK » Thu Feb 18, 2016 2:12 am

FDA grants ocrelizumab 'breakthrough therapy designation' for primary progressive MS

Roche Holding AG announced yesterday that it had received 'breakthrough therapy designation' from the U.S. Food and Drug Administration for the multiple sclerosis treatment ocrelizumab. This will likely speed up market authorisation in six to seven months instead of the usual 10 to 12 months...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2671
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: FDA grants ocrelizumab 'breakthrough therapy designation

Postby 1eye » Thu Feb 18, 2016 7:02 am

There are a lot of things called "breakthroughs" covering many of the MSUK press releases. What about us SPMS patients? Divide and conquer again? Do you have to have some youth left for it to work?
"Try - Just A Little Bit Harder" - Janis Joplin
CCSVI procedure Albany Aug 2010
'MS' is over - if you want it
Patients sans/without patience
User avatar
1eye
Family Elder
 
Posts: 3490
Joined: Wed Mar 17, 2010 4:00 pm
Location: Kanata, Ontario, Canada

Re: FDA grants ocrelizumab 'breakthrough therapy designation

Postby MSUK » Thu Feb 18, 2016 7:12 am

Hi, 1eye,

Bit confused by your post.

Not sure what you mean, as these are not MS-UK related and are not press releases put out by ourselves. We are just reporting MS news stories as they are released on the internet.

With regards the 'Breakthrough Therapy Designation' this is an official FDA designation for certain new medical therapies.

Hope that clarifies things a little.
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2671
Joined: Wed Oct 14, 2009 3:00 pm

Re: FDA grants ocrelizumab 'breakthrough therapy designation

Postby David1949 » Thu Feb 18, 2016 12:48 pm

Note that the original source for this article is the Wall Street Journal.
Maybe the drug manufacturer just wanted to boost their stock price.
David1949
Family Elder
 
Posts: 744
Joined: Mon Aug 23, 2010 3:00 pm

Re: FDA grants ocrelizumab 'breakthrough therapy designation

Postby SarahLonglands » Thu Feb 18, 2016 2:29 pm

This is from Wikipedia:

In March 2010, Roche announced the suspension of clinical trials in rheumatoid arthritis and lupus erythematosus. This step followed excess deaths due to opportunistic infections. Development for multiple sclerosis continues.[6]

So, the trial was stopped due to too many deaths due to opportunistic infections, so what about people with MS? They can fall prey to opportunistic infections just as much! Sarah
An Itinerary in Light and Shadow Completed Dr Charles Stratton / Dr David Wheldon abx regime for aggressive secondary progressive MS in June 2007, after four years. Still improving with no relapses since starting. Can't run but can paint all day.
SarahLonglands
Family Elder
 
Posts: 2167
Joined: Thu Jun 17, 2004 3:00 pm
Location: Bedfordshire UK


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service